Vertex Pharmaceuticals Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $5.08B | $4.57B | $10.37B | $10.50B | $6.80B | $5.99B | $3.11B | $2.65B |
| Accounts Receivable | $2.05B | $1.61B | $1.56B | $1.44B | $1.14B | $885.4M | $633.5M | $409.7M |
| Inventory | $1.69B | $1.21B | $738.8M | $460.6M | $353.1M | $280.8M | $167.5M | $124.4M |
| Total Current Assets | $11.20B | $9.60B | $14.14B | $13.23B | $9.56B | $8.13B | $4.82B | $3.84B |
| Property, Plant & Equipment | — | — | — | — | — | — | $758.1M | $812.0M |
| Goodwill | $1.09B | $1.09B | $1.09B | $1.09B | $1.00B | $1.00B | $1.00B | $50.4M |
| Intangible Assets (Excl. Goodwill) | $424.2M | $825.9M | $839.9M | $603.6M | $400.0M | $400.0M | $400.0M | $0 |
| Total Assets | $25.64B | $22.53B | $22.73B | $18.15B | $13.43B | $11.75B | $8.32B | $6.25B |
| Liabilities | ||||||||
| Accounts Payable | $461.7M | $413.0M | $364.9M | $303.9M | $195.0M | $155.1M | $87.6M | $111.0M |
| Total Current Liabilities | $3.86B | $3.56B | $3.55B | $2.74B | $2.14B | $1.88B | $1.33B | $1.12B |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $6.98B | $6.12B | $5.15B | $4.24B | $3.33B | $3.07B | $2.23B | $1.81B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $13.56B | $9.61B | $10.14B | $6.52B | $3.20B | $858.7M | $-1.85B | $-2.99B |
| Total Stockholders' Equity | $18.67B | $16.41B | $17.58B | $13.91B | $10.10B | $8.69B | $6.09B | $4.44B |